The first ever U.S. clinical guidelines to diagnose and treat adult ADHD are expected to be released this fall. The guidelines are being developed by the American Professional Society of ADHD and Related Disorders (APSARD) due to a lack of existing standards and to improve accuracy of diagnosis and treatment. Experts believe the guidelines will help clinicians, especially primary care physicians, better diagnose and treat adult ADHD, and dispel myths surrounding the disorder.

For more details on the reasons behind the guideline development and the challenges of diagnosing adult ADHD, read the full article here: https://www.medscape.com/viewarticle/first-us-adult-adhd-guidelines-finally-way-2024a10006yf?form=fpf

A recent study published in the National Institutes of Health’s National Center for Biotechnology Information investigated racial bias in how children are diagnosed with ADHD. Researchers looked at data from nearly 4,000 children undergoing neuropsychological evaluations at an outpatient clinic. The study found that teachers were more likely to rate Black children as having more inattentive symptoms and conduct problems compared to White children, regardless of whether the child was actually diagnosed with ADHD.

This study highlights the importance of considering potential racial bias in ADHD diagnoses.

To learn more about the details of this study, check out the full article here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985113/

The national shortage of ADHD medications, including Adderall, Ritalin, Focalin, and Vyvanse, continues to impact millions of individuals and their families. In response, a member of APSARD, was recently featured in an NBC News article discussing the challenges and potential solutions.

Read the full article here: https://www.nbcnews.com/now/video/patients-and-families-frustrated-with-years-long-adhd-drug-shortage-203743301950